Antibiotic releasing hydroxyapatite beads

Takashi Osada, Keiko Yamamura, Kohji Yano, Toshitaka Nabeshima, Hisashi Iwata, Toshihisa Yotsuyanagi

Research output: Contribution to journalArticle

Abstract

Synthesis hydroxyapatite (HAP), similar to bone or tooth mineral composition, was developed for bone grafts in dental and orthopedic applications. Common skin microorganisms, such as Staphylococcus aureus and Staphylococcus epidermidis, have been associated with bone graft-related infections. We investigated whether an antibiotic controlled-releasing HAP device would reduce bacterial organisms at the operated site. Cefotiam (CTM) was used as a model antibiotic since it possesses activity against Staphylococcus aureus and Staphylococcus epidermidis. To control the release rate of CTM, egg phosphatidylcholine (EPC) was loaded into a HAP bead (diameter : 8.48 mm, weight : 531 mg). The EPC-HAP beads were placed in CTM aqueous solutions(4-25 mg/ml) under atmospheric pressure. A bead containing CTM solution in its internal pores was referred to as a “wet CTM-EPC-HAP bead”. In vitro release studies demonstrated that the release rate of CTM decreased with the increase of EPC load. One wet CTM-EPC-HAP bead was implanted in the skin pocket made in a rat, and inoculated with Staphylococcus aureus or Staphylococcus epidermidis (107CFU/ml). Wet CTM-EPC-HAP beads showed less Staphylococcus aureus and Staphylococcus epidermidis in comparison with the control HAP beads two days after inoculation. These studies suggest that antibiotic controlled-releasing HAP delivery can decrease infections at the operated site of patients undergoing bone grafts.

Original languageEnglish
Pages (from-to)431-435
Number of pages5
JournalDrug Delivery System
Volume10
Issue number6
DOIs
Publication statusPublished - 01-01-1995

Fingerprint

Cefotiam
Durapatite
Anti-Bacterial Agents
Phosphatidylcholines
Ovum
Staphylococcus epidermidis
Staphylococcus aureus
Bone and Bones
Transplants
Tooth
Skin
Atmospheric Pressure
Infection
Orthopedics
Minerals
Weights and Measures
Equipment and Supplies

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science

Cite this

Osada, T., Yamamura, K., Yano, K., Nabeshima, T., Iwata, H., & Yotsuyanagi, T. (1995). Antibiotic releasing hydroxyapatite beads. Drug Delivery System, 10(6), 431-435. https://doi.org/10.2745/dds.10.431
Osada, Takashi ; Yamamura, Keiko ; Yano, Kohji ; Nabeshima, Toshitaka ; Iwata, Hisashi ; Yotsuyanagi, Toshihisa. / Antibiotic releasing hydroxyapatite beads. In: Drug Delivery System. 1995 ; Vol. 10, No. 6. pp. 431-435.
@article{d8cdcc3e4449492880078211a4757611,
title = "Antibiotic releasing hydroxyapatite beads",
abstract = "Synthesis hydroxyapatite (HAP), similar to bone or tooth mineral composition, was developed for bone grafts in dental and orthopedic applications. Common skin microorganisms, such as Staphylococcus aureus and Staphylococcus epidermidis, have been associated with bone graft-related infections. We investigated whether an antibiotic controlled-releasing HAP device would reduce bacterial organisms at the operated site. Cefotiam (CTM) was used as a model antibiotic since it possesses activity against Staphylococcus aureus and Staphylococcus epidermidis. To control the release rate of CTM, egg phosphatidylcholine (EPC) was loaded into a HAP bead (diameter : 8.48 mm, weight : 531 mg). The EPC-HAP beads were placed in CTM aqueous solutions(4-25 mg/ml) under atmospheric pressure. A bead containing CTM solution in its internal pores was referred to as a “wet CTM-EPC-HAP bead”. In vitro release studies demonstrated that the release rate of CTM decreased with the increase of EPC load. One wet CTM-EPC-HAP bead was implanted in the skin pocket made in a rat, and inoculated with Staphylococcus aureus or Staphylococcus epidermidis (107CFU/ml). Wet CTM-EPC-HAP beads showed less Staphylococcus aureus and Staphylococcus epidermidis in comparison with the control HAP beads two days after inoculation. These studies suggest that antibiotic controlled-releasing HAP delivery can decrease infections at the operated site of patients undergoing bone grafts.",
author = "Takashi Osada and Keiko Yamamura and Kohji Yano and Toshitaka Nabeshima and Hisashi Iwata and Toshihisa Yotsuyanagi",
year = "1995",
month = "1",
day = "1",
doi = "10.2745/dds.10.431",
language = "English",
volume = "10",
pages = "431--435",
journal = "Drug Delivery System",
issn = "0913-5006",
publisher = "Japan Society of Drug Delivery System",
number = "6",

}

Osada, T, Yamamura, K, Yano, K, Nabeshima, T, Iwata, H & Yotsuyanagi, T 1995, 'Antibiotic releasing hydroxyapatite beads', Drug Delivery System, vol. 10, no. 6, pp. 431-435. https://doi.org/10.2745/dds.10.431

Antibiotic releasing hydroxyapatite beads. / Osada, Takashi; Yamamura, Keiko; Yano, Kohji; Nabeshima, Toshitaka; Iwata, Hisashi; Yotsuyanagi, Toshihisa.

In: Drug Delivery System, Vol. 10, No. 6, 01.01.1995, p. 431-435.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Antibiotic releasing hydroxyapatite beads

AU - Osada, Takashi

AU - Yamamura, Keiko

AU - Yano, Kohji

AU - Nabeshima, Toshitaka

AU - Iwata, Hisashi

AU - Yotsuyanagi, Toshihisa

PY - 1995/1/1

Y1 - 1995/1/1

N2 - Synthesis hydroxyapatite (HAP), similar to bone or tooth mineral composition, was developed for bone grafts in dental and orthopedic applications. Common skin microorganisms, such as Staphylococcus aureus and Staphylococcus epidermidis, have been associated with bone graft-related infections. We investigated whether an antibiotic controlled-releasing HAP device would reduce bacterial organisms at the operated site. Cefotiam (CTM) was used as a model antibiotic since it possesses activity against Staphylococcus aureus and Staphylococcus epidermidis. To control the release rate of CTM, egg phosphatidylcholine (EPC) was loaded into a HAP bead (diameter : 8.48 mm, weight : 531 mg). The EPC-HAP beads were placed in CTM aqueous solutions(4-25 mg/ml) under atmospheric pressure. A bead containing CTM solution in its internal pores was referred to as a “wet CTM-EPC-HAP bead”. In vitro release studies demonstrated that the release rate of CTM decreased with the increase of EPC load. One wet CTM-EPC-HAP bead was implanted in the skin pocket made in a rat, and inoculated with Staphylococcus aureus or Staphylococcus epidermidis (107CFU/ml). Wet CTM-EPC-HAP beads showed less Staphylococcus aureus and Staphylococcus epidermidis in comparison with the control HAP beads two days after inoculation. These studies suggest that antibiotic controlled-releasing HAP delivery can decrease infections at the operated site of patients undergoing bone grafts.

AB - Synthesis hydroxyapatite (HAP), similar to bone or tooth mineral composition, was developed for bone grafts in dental and orthopedic applications. Common skin microorganisms, such as Staphylococcus aureus and Staphylococcus epidermidis, have been associated with bone graft-related infections. We investigated whether an antibiotic controlled-releasing HAP device would reduce bacterial organisms at the operated site. Cefotiam (CTM) was used as a model antibiotic since it possesses activity against Staphylococcus aureus and Staphylococcus epidermidis. To control the release rate of CTM, egg phosphatidylcholine (EPC) was loaded into a HAP bead (diameter : 8.48 mm, weight : 531 mg). The EPC-HAP beads were placed in CTM aqueous solutions(4-25 mg/ml) under atmospheric pressure. A bead containing CTM solution in its internal pores was referred to as a “wet CTM-EPC-HAP bead”. In vitro release studies demonstrated that the release rate of CTM decreased with the increase of EPC load. One wet CTM-EPC-HAP bead was implanted in the skin pocket made in a rat, and inoculated with Staphylococcus aureus or Staphylococcus epidermidis (107CFU/ml). Wet CTM-EPC-HAP beads showed less Staphylococcus aureus and Staphylococcus epidermidis in comparison with the control HAP beads two days after inoculation. These studies suggest that antibiotic controlled-releasing HAP delivery can decrease infections at the operated site of patients undergoing bone grafts.

UR - http://www.scopus.com/inward/record.url?scp=85024300118&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024300118&partnerID=8YFLogxK

U2 - 10.2745/dds.10.431

DO - 10.2745/dds.10.431

M3 - Article

AN - SCOPUS:85024300118

VL - 10

SP - 431

EP - 435

JO - Drug Delivery System

JF - Drug Delivery System

SN - 0913-5006

IS - 6

ER -

Osada T, Yamamura K, Yano K, Nabeshima T, Iwata H, Yotsuyanagi T. Antibiotic releasing hydroxyapatite beads. Drug Delivery System. 1995 Jan 1;10(6):431-435. https://doi.org/10.2745/dds.10.431